tiprankstipranks
Ideaya Biosciences (IDYA)
NASDAQ:IDYA
US Market
IDYA
IDEAYA Biosciences
RESEARCH TOOLSreports
Want to see IDYA full AI Analyst Report?

IDEAYA Biosciences (IDYA) Stock News & Sentiment

676 Followers
Ideaya’s IDE574 Trial Signals New Optionality in Advanced Solid Tumors and Breast Cancer
Premium
Company Announcements
Ideaya’s IDE574 Trial Signals New Optionality in Advanced Solid Tumors and Breast Cancer
4d ago
IDYA
IDEAYA Biosciences Files New Shelf Registration Statement
Premium
Company Announcements
IDEAYA Biosciences Files New Shelf Registration Statement
19d ago
8K
IDYA
IDEAYA, AstraZeneca launch global IDE849-Imfinzi lung cancer trial
Premium
Company Announcements
IDEAYA, AstraZeneca launch global IDE849-Imfinzi lung cancer trial
2M ago
8K
IDYA
IDEAYA Biosciences: Operational Trial Delay but High Conviction Buy Ahead of Key Darovasertib Readout
Premium
Ratings
IDEAYA Biosciences: Operational Trial Delay but High Conviction Buy Ahead of Key Darovasertib Readout
2M ago
IDYA
IDEAYA Biosciences: Expanding Precision Oncology Platform and Refocused MTAP Strategy Support Buy Rating
Premium
Ratings
IDEAYA Biosciences: Expanding Precision Oncology Platform and Refocused MTAP Strategy Support Buy Rating
3M ago
IDYA
IDEAYA Biosciences: Methodologically De-Risked OpTimUM-02 Readout and Strong Cash Runway Support Buy Rating
Premium
Ratings
IDEAYA Biosciences: Methodologically De-Risked OpTimUM-02 Readout and Strong Cash Runway Support Buy Rating
3M ago
IDYA
IDEAYA Biosciences: Pipeline Progress and Late-Stage Clinical Expansion Support Reiterated Buy Rating
Premium
Ratings
IDEAYA Biosciences: Pipeline Progress and Late-Stage Clinical Expansion Support Reiterated Buy Rating
3M ago
IDYA
More IDYA News >

IDYA News on the Web

IDEAYA Biosciences Says Melanoma Drug on Track for NDA After Strong Trial Data
MarketBeat
Bullish
Why IDEAYA Biosciences Shares Are Sliding Now
TipRanks News
Bearish
IDEAYA Biosciences (IDYA) Receives a Buy from LifeSci Capital
TipRanks News
Bullish
Ideaya Biosciences price target lowered to $50 from $52 at Mizuho
TipRanks News
Neutral
Analysts Are Bullish on Top Healthcare Stocks: IDEAYA Biosciences (IDYA), Ardent Health Partners, Inc. (ARDT)
TipRanks News
Bullish
RBC Capital Sticks to Its Buy Rating for IDEAYA Biosciences (IDYA)
TipRanks News
Bullish
IDEAYA Biosciences (IDYA) Receives a Buy from Truist Financial
TipRanks News
Bullish
IDEAYA Biosciences Files New Shelf Registration Statement
TipRanks News
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
IDYA
Sector Average
Media Buzz
This Week2 articles
Weekly Average3.5 articles
News Sentiment
This Week59%
Sector Average78%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is IDYA’s Media Buzz Sentiment?
2 articles about IDYA were published this week. In an average week, 3.5 articles are published.
    What is IDYA’s weekly average amount of articles?
    In an average week, 3.5 articles about IDYA are published.
      What is IDYA’s News Sentiment?
      59% of articles about IDYA were positive this week, compared to its sector average of 78%.
        Healthcare Stocks that are Trending in the News
        GOSSGossamer Bio
        RLAYRelay Therapeutics
        ROIVRoivant Sciences
        ILAIsland Pharmaceuticals Ltd
        TLSATiziana Life Sciences
        Showing the stocks with the most bullish news sentiment over the past week